Current:Home > MarketsFDA approves a new antibody drug to prevent RSV in babies-LoTradeCoin
FDA approves a new antibody drug to prevent RSV in babies
View Date:2024-12-23 15:59:32
This fall, for the first time many babies in the U.S. will be able to get a shot to fend off RSV, a respiratory virus that can cause serious lung disease in infants and young children.
The Food and Drug Administration Monday approved nirsevimab, a single shot of antibodies that was shown in clinical trials to lower the need for medical care from RSV for babies by 70-75%.
Respiratory syncytial virus, or RSV is a viral infection that puts between 58,000 to 80,000 young children in the hospital each year, making it the leading cause of hospitalization among infants in the U.S.
"Today's approval addresses the great need for products to help reduce the impact of RSV disease on children, families and the health care system," said Dr. John Farley, director of the Office of Infectious Diseases in the FDA's Center for Drug Evaluation and Research in a statement.
The treatment can be used to protect infants' during their first RSV season. It is also approved to provide protection during a second season for children up to 2 years old and at risk of severe RSV disease.
Drugmakers AstraZeneca and Sanofi plan to start offering the treatment – which will be marketed as Beyfortus – in time for the upcoming RSV season this fall when respiratory viruses spread widely in much of the country.
They have not announced a price for the product, though a spokesperson for Sanofi says it will be similar to a series of HPV vaccines. For comparison, the recommended series of HPV vaccines for young children costs more than $500 on the commercial market.
In June, a panel of advisers to the FDA had recommended that the agency approve the new antibody drug.
There was unanimous support on the 21-person committee for approving the drug's use in infants ahead of or during their first RSV season. And, in a separate vote, all but two members of the panel supported giving the drug to infants with medical risks through their second RSV season. The FDA ultimately approved it for both uses.
"This is one of the most important infectious diseases in the pediatric population," said Dr. Mary Anne Jackson, a pediatrician at Children's Mercy in Kansas City, Missouri and a voting member.
Members of the committee said the data presented by the drugmakers, AstraZeneca and Sanofi, and the FDA demonstrated that nirsevimab appears to be safe and effective.
According to AstraZeneca's analysis, most RSV hospitalizations could be prevented with use of this drug.
In two clinical trials, involving nearly 3,000 babies, a single shot of the monoclonal antibody reduced the risks of an RSV case that required medical attention by 70-75%, and lowered the risks of hospitalization by 60-80%. High levels of the antibody persisted for at least five months. Side effects, including rashes and fevers, were uncommon and generally mild.
"This is a pathogen that has a substantial impact on the lives of young children, causing significant morbidity and mortality" and limits the ability of children who are sick with other illnesses to get medical care, says Dr. Steven Krug, a pediatric emergency physician and professor at the Northwestern University Feinberg School of Medicine.
Nirsevimab's approval broadens the protection available for babies. Prior to this approval the only existing preventive drug was a monoclonal antibody shot called palivizumab which requires monthly administration and is reserved for babies at high medical risk.
Dr. Marcus Plescia, chief medical officer for the Association of State and Territorial Health Officers, says it may take awhile for parents to warm up to the new drug. "It's recommended very soon after birth," he says. "A lot of parents are a little bit cautious about wanting to give really young children things. So it may take a little bit of time to really build confidence in the monoclonal antibody."
Authorities in the EU approved the antibody last fall, and it is currently being considered for use in several Asian countries.
This antibody shot is one of several new drugs and vaccines in development to protect babies and the elderly from RSV. The FDA is expected to issue a decision on an RSV vaccine to protect newborns that is given to pregnant mothers by late August.
This story has been updated. It originally ran June 8.
veryGood! (6393)
Related
- Opinion: NFL began season with no Black offensive coordinators, first time since the 1980s
- Prince Harry Returns to London for WellChild Awards Ahead of Queen Elizabeth II's Death Anniversary
- From snow globes to tutoring, strikes kick Hollywood side hustles into high gear
- House of Villains' OMG Trailer Teases Spencer Pratt, a Real Housewife & More Surprise Guests
- Disease could kill most of the ‘ohi‘a forests on Hawaii’s Big Island within 20 years
- Jets’ Aaron Rodgers shows support for unvaccinated tennis star Novak Djokovic
- Mission underway to rescue American who fell ill while exploring deep cave in Turkey
- As U.S. warns North Korea against giving Russia weapons for Ukraine, what could Kim Jong Un get in return?
- Amazon's 'Cross' almost gets James Patterson detective right: Review
- Former British police officers admit sending racist messages about Meghan and others
Ranking
- Kraft Heinz stops serving school-designed Lunchables because of low demand
- Kourtney Kardashian says baby is safe after urgent fetal surgery: I will be forever grateful
- Grizzly bear suspected of maulings near Yellowstone area killed after breaking into house
- Peloton instantly kills man by severing artery, lawsuit claims
- Minnesota county to pay $3.4M to end lawsuit over detainee’s death
- Daughter of long-imprisoned activist in Bahrain to return to island in bid to push for his release
- Special counsel intends to bring indictment against Hunter Biden by month's end
- Australian minister says invasive examinations were part of reason Qatar Airways was refused flights
Recommendation
-
The Latin Grammys are almost here for a 25th anniversary celebration
-
Severe flooding in Greece leaves at least 6 dead and 6 missing, villages cut off
-
Poland bank governor says interest rate cut justified by falling inflation
-
Grizzly bear suspected of maulings near Yellowstone area killed after breaking into house
-
How Jersey Shore's Sammi Sweetheart Giancola's Fiancé Justin May Supports Her on IVF Journey
-
Why Matthew McConaughey Let Son Levi Join Social Media After Years of Discussing Pitfalls
-
A Democratic prosecutor is challenging her suspension by Republican Florida Gov. Ron DeSantis
-
Dog food recall: Victor Super Premium bags recalled for potential salmonella contamination